Clinical Trials on Pregestational Diabetes in United Kingdom

Total 8030 results

Novo Nordisk A/S

Completed

Pharmacokinetics and Pharmacodynamics of Biphasic Insulin Aspart 30 in Healthy Volunteers

Healthy | Diabetes

United Kingdom
LifeScan

Completed

Diabetic Mellitus Patients Glucose Range Awareness After Experiencing a New Blood Glucose Meter Feature

Diabetes Mellitus

United Kingdom
Novo Nordisk A/S

Completed

Investigation on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of a Long Acting GLP-1 Analogue (NNC0113-0987) in Healthy Male Subjects

Healthy | Diabetes

United Kingdom
University of Michigan
Eli Lilly and Company; Amylin Pharmaceuticals, LLC.

Completed

Evaluation of Exenatide in Patients With Diabetic Neuropathy

Type 2 Diabetes Mellitus | Diabetic Peripheral Neuropathy

United States
Sirtris, a GSK Company
GlaxoSmithKline

Completed

A Clinical Study to Assess the Effect of Food and Gender on the Pharmacokinetics of SRT2104 Administered as an Oral Suspension or Capsule Formulation to Normal Healthy Volunteers

Diabetes Mellitus, Type 2

United Kingdom
GlaxoSmithKline

Completed

A Clinical Study to Assess the Safety and Pharmacokinetics of SRT2379 in Normal Healthy Male Volunteers

Diabetes Mellitus, Type 2

United Kingdom
University of Leicester
University Hospitals, Leicester

Completed

The Effects of an 8-week Vegan Diet on TMAO Levels and Post-challenge Glucose Levels in Individuals With Dysglycaemia (PYH)

Heart Diseases | Diabetes Mellitus, Type 2

United Kingdom
LifeScan Scotland Ltd

Completed

Project VerioVue Enhancements - Arterial Study

Diabetes Mellitus

United Kingdom
Novo Nordisk A/S

Completed

Pharmacoscintigraphic Investigation of NN9924 in Healthy Male Subjects

Healthy | Diabetes

United Kingdom
University of Oxford
Oxford University Hospitals NHS Trust

Completed

Glucagon in MODY (Maturity Onset Diabetes of the Young)

MODY1 | MODY3

United Kingdom
University of Exeter
Wellcome Trust; University of Dundee; Department of Health, United Kingdom

Completed

Using Pharmacogenetics to Improve Treatment in Early-onset Diabetes (UNITED)

Diabetes

United Kingdom
GlaxoSmithKline

Completed

Immune Profile in Subjects With New Onset Type 1 Diabetes

Diabetes Mellitus, Type 1

United Kingdom
University of Edinburgh
Chief Scientist Office of the Scottish Government

Completed

A Feasibility Study Looking at the Use of Glibenclamide and metfoRmin Versus stAndard Care in gEstational diabeteS (GRACES)

Pregnancy | Gestational Diabetes

United Kingdom
LifeScan Scotland Ltd
MAC Clinical Research

Completed

Clinical Evaluation of LifeScan Blood Glucose Monitoring Systems

Diabetes Mellitus

United Kingdom
Novo Nordisk A/S

Completed

Safety and Tolerability of Liraglutide in Healthy Male Volunteers

Healthy | Diabetes

United Kingdom
Novo Nordisk A/S

Completed

Evaluation of Optimal Dosing Conditions for GLP-1 Analogue NNC0113-0987 When Administered Orally in Healthy Male Subjects

Healthy | Diabetes

United Kingdom
Novo Nordisk A/S

Completed

Pharmacokinetics, Pharmacodynamics and Safety of Biphasic Insulin Aspart 30 in Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

Netherlands, United Kingdom
Medtronic Diabetes

Completed

User Evaluation of the MiniMed 620G and 640G Insulin Pumps

Type 1 Diabetes | Type 2 Diabetes

United Kingdom, Denmark, Australia, Spain
Queen Mary University of London
The Novo Nordisk UK Research Foundation

Completed

Are Diabetics Type 2 More Prone to Dental Caries?

Diabetes Mellitus, Type 2 | Dental Caries

United Kingdom
University of Birmingham
Heart of England NHS Trust

Completed

Obstructive Sleep Apnoea in Patients With Type 1 Diabetes

Type 1 Diabetes | Obstructive Sleep Apnoea

United Kingdom
Matthew Grout

Completed

Utilizing Glycaemic Index: An Investigation of the Glycaemia and Cognition in Type 2 Diabetes

Diabetes Mellitus, Type 2 | Cognitive Impairment

United Kingdom
Sanofi

Completed

Comparison of Glucose Values and Variability Between TOUJEO and TRESIBA During Continuous Glucose Monitoring in Type 1 Diabetes Patients (inRange)

Type 1 Diabetes Mellitus

Turkey, Netherlands, Brazil, United States, Germany, Hungary, United Kingdom
University of Oxford
Oxford Brookes University; The Leona M. and Harry B. Helmsley Charitable Trust

Terminated

Dapagliflozin During Exercise for the PrevenTion of Hypoglycaemia (DEPTH)

Diabetes Mellitus, Type 1

United Kingdom
GlaxoSmithKline

Completed

Effect of Darapladib on Cantharidin-Induced Inflammatory Blisters in Subjects With Type 2 Diabetes Mellitus (T2DM)

Atherosclerosis

United Kingdom
Perspectum

Recruiting

MultiOrgan Multi-Parametric MRI Study (MORIS)

Type 2 Diabetes

United Kingdom
University of Aberdeen

Recruiting

Effect of Soft Fruit on Postprandial Blood Glucose

Type 2 Diabetes

United Kingdom
University of Edinburgh
NHS Lothian

Unknown

The Effects of Lipoic Acid on Glycaemic Control in Type 2 Diabetes

Diabetes Mellitus, Type 2

United Kingdom
Boehringer Ingelheim

Completed

HORNBILL: A Study to Test Different Doses of BI 764524 in Patients Who Have Had Laser Treatment for a Type of Diabetic Eye Disease Called Diabetic Retinopathy With Diabetic Macular Ischemia (HORNBILL)

Diabetic Retinopathy

United States, United Kingdom
University of Bath
Teagasc

Active, not recruiting

Identification of New Biomarkers of Insulin Resistance

Inflammation | Diabetes Mellitus, Type 2 | Insulin Resistance | Gastrointestinal Microbiome

United Kingdom
Sirtris, a GSK Company
GlaxoSmithKline

Completed

A Clinical Study to Assess the Safety and Pharmacokinetics of SRT2104 in Normal Healthy Male Volunteers

Diabetes Mellitus, Type 2 | Healthy Volunteer

United Kingdom
University of Dundee

Completed

Study of Sulphonylurea Synergy With DPP4 Inhibitors (SSS)

Type 2 Diabetes

United Kingdom
The Royal Bournemouth Hospital

Completed

Influence of Binge Drinking on Glucose Metabolism in Patients With Type 1 Diabetes - A Pilot Study

Diabetes Mellitus, Type 1

United Kingdom
University of Liverpool
St Helens & Knowsley Teaching Hospitals NHS Trust

Not yet recruiting

Differing Completion Rates of DIABETES Education on Patient Reported Outcomes (DIABETES-PRO)

Diabetes Mellitus, Type 2 | Patient Education as Topic

United Kingdom
Amalgam Rx, Inc.
Kansas City Area Life Sciences Institute, Inc.; University of Kansas; LifeScan

Unknown

mHealth Titration and Management

Diabetes Mellitus, Type 2 | Diabetic Complication

United States
Nottingham University Hospitals NHS Trust
Diabetes UK

Completed

Evaluation of Education in the Secondary Prevention of Foot Ulceration in Diabetes (ESP)

Foot Ulceration in Diabetes

United Kingdom
Imperial College London

Completed

The Metabolic Profile in Intrahepatic Cholestasis of Pregnancy and Diabetes Mellitus

Gestational Diabetes Mellitus | Intrahepatic Cholestasis of Pregnancy

United Kingdom
Great Ormond Street Hospital for Children NHS Foundation...
University College, London

Unknown

The Use of Home Oral Glucose Tolerance Test Kit in Screening Cystic Fibrosis Related Diabetes (HomeOGTT)

Cystic Fibrosis | Cystic Fibrosis Related Diabetes

United Kingdom
Novo Nordisk A/S

Completed

Comparison of Human Insulin Produced by the Current Process and the NN729 Process in Healthy Volunteers

Healthy | Diabetes

United Kingdom
Royal Devon and Exeter NHS Foundation Trust

Completed

Effect of Food Composition on Postprandial Insulin Secretion in Neonatal Diabetes (FoND)

Neonatal Diabetes

United Kingdom
King's College London
National Institute for Health Research, United Kingdom; South London and Maudsley...

Completed

Electronic Clinical Decision Support for Diabetes and Dysglycaemia in Secondary Mental Healthcare

Diabetes Mellitus | Dysglycemia | Severe Mental Disorder | Staff Attitude

United Kingdom
Astellas Pharma Europe B.V.

Completed

A Study Into Pain Relief Given by ASP8477 for Peripheral Neuropathic Pain (Either Post-herpetic Neuralgia or Painful Diabetic Peripheral Neuropathy) and Its Safety (MOBILE)

Neuropathic Pain | Post-Herpetic Neuralgia (PHN) | Painful Diabetic Peripheral Neuropathy (PDPN)

Czechia, Germany, Poland, United Kingdom
AstraZeneca

Terminated

ARAMIS: Actions of tesaglitazaR on fAt Metabolism and Insulin Sensitivity

Type 2 Diabetes

Italy, Finland, United Kingdom
Imperial College London
University of Edinburgh; Universidad de Granada; University of Leicester

Active, not recruiting

Diagnostic Tools to Establish the Presence and Severity of Peripheral Arterial Disease in People With Diabetes (DM PAD)

Diabetic Foot | Peripheral Arterial Disease | Peripheral Vascular Diseases | Diabetic Foot Ulcer | Peripheral Artery Disease | Critical Limb Ischemia | Critical Lower Limb Ischemia

United Kingdom
Imperial College London
London Ambulance Service

Terminated

Assessment of the Impact of Real-Time Continuous Glucose Monitoring on People Presenting With Severe Hypoglycaemia (AIR-CGM)

Hypoglycemia | Diabetes Mellitus, Type 1 | Hypoglycemia Unawareness

United Kingdom
University of Leicester
National Institute for Health Research, United Kingdom; National Health Service...

Completed

FIT 2 SIT - Are Metabolic Responses to Sitting/Light Breaks Mediated by Fitness? (FIT2SIT)

Diabetes

United Kingdom
Novo Nordisk A/S

Completed

Comparison of Insulin Detemir Produced by the Current Process and the NN729 Process in Healthy Subjects

Healthy | Diabetes

United Kingdom
Novo Nordisk A/S

Completed

Comparison of Two Insulin Detemir Formulations in Healthy Volunteers

Healthy | Diabetes

United Kingdom
University of Aberdeen

Completed

Effect of Fish Oil on Insulin Sensitivity

Type 2 Diabetes Mellitus | Sarcopenia | Metabolic Syndrome X

United Kingdom
University of Lincoln

Completed

Ambulance 'Hypos Can Strike Twice' Study (Ambu-HS2)

Diabetes

United Kingdom
University of Leicester
National Institute for Health Research, United Kingdom; National Health Service...

Completed

Arming Health: Can Breaking up Restful Sitting Time With Upper Body Contractile Activity Regulate Metabolic Health. (AYH)

Diabetes

United Kingdom

Clinical Trials on Pregestational Diabetes in United Kingdom

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo, DR of

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations